The mortality of patients with estrogen-receptor-positive breast cancer was much higher than that of patients whose expression of estrogen receptors was negative, and the mortality of estrogen-dependent Luminal A breast cancer was the lowest among pathological molecular types, which was consistent with the previous reports [23,24]. Here, ESR1 is linked to breast carcinoma.